We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Deja Rose

Deja R. Rose MD

Clinical Neuroimmunology Fellow, Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio

Dr. Rose is a Clinical Research Neuroimmunology Fellow at the Mellen Center for Multiple Sclerosis at the Cleveland Clinic. She is also completing a Masters in Clinical Research at Case Western Reserve University. She received a BS in Neurobiology from Georgetown University in 2010 and an MD from Tulane University School of Medicine in 2016. She completed her Neurology Residency at Thomas Jefferson University in 2020, serving as a Chief Resident from 2019-2020. Her research interests include disparities in MS outcomes and predictions in treatment response. 

Disclosures

Dr. Rose has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Smoking Cessation May Improve Disability Progression in MS